STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 3] MEI Pharma, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Alexander Schornstein filed a Form 3 disclosing initial beneficial ownership in Lite Strategy, Inc. (MEIP). The filing reports ownership of 4,365,472 shares of Common Stock, of which 4,140,472 are held directly by Mr. Schornstein and 225,000 are held by Camino Capital GmbH, an entity of which he is the sole beneficial owner and holds sole voting power.

The filing indicates a reporting relationship to the issuer as a director and was dated as the event on 09/09/2025 with a signature dated 09/10/2025. No derivative securities or exercise terms were reported.

Positive
  • Clear disclosure of both direct and indirect holdings, including the split between personal holdings and those held through Camino Capital GmbH
  • No derivative securities reported, indicating no immediate dilution from options, warrants, or convertible instruments disclosed on this Form 3
Negative
  • None.

Insights

TL;DR: Director disclosed meaningful direct and indirect stock ownership, consolidating voting control through a private entity.

The Form 3 shows Mr. Schornstein holds a combined 4,365,472 common shares, including 225,000 held via Camino Capital GmbH where he is sole beneficial owner and sole voting power. This structure centralizes voting influence and aligns director interests with shareholders. The filing contains no derivative positions and no amendments. From a governance perspective, clear disclosure of indirect holdings and voting power is standard and helps market transparency.

TL;DR: Initial ownership disclosure is neutral operationally but relevant for shareholding composition.

The Form 3 is an administrative disclosure of beneficial ownership rather than an operational development. It confirms a director-level insider has a notable equity stake of 4,365,472 shares. There are no reported transactions, option grants, or convertible instruments in this filing, so immediate financial impact or dilution is not indicated. Investors gain clarity on insider stake and voting alignment.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Schornstein Alexander

(Last) (First) (Middle)
KAISER-FRIEDRICH-ALLEE 2

(Street)
AACHEN 2M 52074

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/09/2025
3. Issuer Name and Ticker or Trading Symbol
Lite Strategy, Inc. [ MEIP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.00000002 4,365,472(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 4,140,472 shares of Common Stock held by Alexander Schornstein and 225,000 shares of Common Stock held by Camino Capital GmbH, in which Alexander Schornstein is the sole beneficial owner and has sole voting power.
/s/ Alexander Schornstein 09/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alexander Schornstein disclose on the Form 3 for MEIP?

He disclosed beneficial ownership of 4,365,472 shares of Lite Strategy, Inc. common stock, comprising 4,140,472 held personally and 225,000 held by Camino Capital GmbH.

What is the reporting relationship of Alexander Schornstein to the issuer?

The filing indicates Mr. Schornstein is a director of the issuer. The form also marks the 10% owner box in the reporting section.

Were any derivative securities reported on this Form 3 for MEIP?

No. The Form 3 lists no derivative securities, exercise dates, expiration dates, or conversion terms.

When was the event date and signature date on the filing?

The event requiring the statement is dated 09/09/2025 and the filing is signed on 09/10/2025.

Who holds voting power over the shares held by Camino Capital GmbH?

The filing states Alexander Schornstein is the sole beneficial owner of Camino Capital GmbH and has sole voting power over the 225,000 shares held by that entity.
Mei Pharma Inc

NASDAQ:MEIP

MEIP Rankings

MEIP Latest News

MEIP Latest SEC Filings

MEIP Stock Data

100.81M
30.34M
14.45%
8.13%
8.04%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO